On Demand 2016 Practical Advice for the Diagnosis/Management of Drug Allergy (MOC)
Price: $24 members, $36 non-members
You can earn up to 1.5 AMA PRA Category 1 Credit(s)™. This activity has also been designated by the ABAI for 1.5 MOC Part II Self-Assessment credits.
The majority of patients reporting penicillin allergy are not truly allergic. Avoidance of penicillin/beta-lactam antibiotics leads to using broader-spectrum, more expensive antibiotics. Rapid desensitization pursued unnecessarily also results in higher costs. This session will allow participants to optimize evaluations of patients reporting drug allergies, leading to improved, cost-effective care.
Release Date: 12/01/2016
Expiration Date: 11/30/2019
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Optimize the evaluation of a patient reporting a drug allergy using a focused history
- Discuss cost effective methods for using skin testing and drug challenge to evaluate patients reporting a drug allergy
- Understand when cephalosporins can be used safely despite a history of PCN allergy
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance
- 1.50 MOC